At Novartis, we’re committed to unraveling the inner workings of cancer. We’re developing new therapies for a range of common and rare cancers, investing in diverse technology platforms and experimenting with combination approaches.

Reimagining medicine in cancer

We have the passion and the people to help transform lives as we pursue treatments for patients.

Our disease areas

At Novartis, we push the limits of science to develop innovative therapies. These therapies have the potential to be new foundations for cancer care in areas with great unmet need.

Doctor examining rwandan patient

Breast cancer

Novartis is committed to driving measurable change by addressing disparities in breast cancer care. Our priority over the past 30 years and today is to deliver targeted therapies to potentially improve quality of life and extend lives for those diagnosed with breast cancer as we work towards a cure.

Elder woman holding hand of a patient

Lung cancer

Lung cancer is the number one cause of cancer-related deaths worldwide. With one of the most diverse drug development programs in the industry, our work in lung cancer is focused on making an impact for patients around the world. At Novartis, we are advancing the science to drive treatment for lung cancer.
Doctor greeting a patient

Prostate cancer

We are harnessing the innovation of our world-class scientists, strategic partnerships, and one of the industry’s most competitive pipelines to explore the potential of our targeted therapies to address unmet needs in prostate cancer. Our goal is to reduce the global disease burden, extend the lives of patients with prostate cancer, and elevate current standards of care.
Doctor testing blood pressure

Hematology

From targeted therapies, to precision cell and gene therapy and immunotherapy – we have been pioneers in hematology, staying on the cutting edge in order to tackle blood cancers and serious blood disorders. Our research continues in new and different ways to harness the power of immunotherapy and potentially benefit a broader patient population than ever before. We are changing the hematological paradigm, transforming what it means to live with blood cancer or a serious blood disorder.

 

Cancer and hematology stories

Portrait of Leanne Pero

Let’s Talk About The C-Word

Talking about cancer can be challenging. Hear from one patient who was inspired to drive change.
Mother and her daughter

Addressing racial disparities in breast cancer screening

Novartis today announced the launch of More Than Just Words, a multiyear commitment to promote health equity in breast cancer.